Institution Decision: Deny | Jun 2, 2025 | PAPER | BOARD |
PATENT OWNER’S SURREPLY IN SUPPORT OF PRELIMINARY RESPONSE | May 7, 2025 | PAPER | PATENT OWNER |
Email from D. Berl to District Court | May 7, 2025 | EXHIBIT | PATENT OWNER |
'992 IPR Decision | Apr 23, 2025 | EXHIBIT | PETITIONER |
'601 IPR Decision | Apr 23, 2025 | EXHIBIT | PETITIONER |
'572 IPR Decision | Apr 23, 2025 | EXHIBIT | PETITIONER |
'681 IPR Decision | Apr 23, 2025 | EXHIBIT | PETITIONER |
'601 IPR Decision | Apr 23, 2025 | EXHIBIT | PETITIONER |
'601 Disclaimer | Apr 23, 2025 | EXHIBIT | PETITIONER |
'601 Disclaimer | Apr 23, 2025 | EXHIBIT | PETITIONER |
'601 Disclaimer | Apr 23, 2025 | EXHIBIT | PETITIONER |
'572 Disclaimer | Apr 23, 2025 | EXHIBIT | PETITIONER |
'992 Disclaimer | Apr 23, 2025 | EXHIBIT | PETITIONER |
First District Court Complaint | Apr 23, 2025 | EXHIBIT | PETITIONER |
Second District Court Complaint | Apr 23, 2025 | EXHIBIT | PETITIONER |
Email re Proposed Scheduling Order | Apr 23, 2025 | EXHIBIT | PETITIONER |
ID in Celltrion '992 IPR | Apr 23, 2025 | EXHIBIT | PETITIONER |
Regeneron May 10 Submission | Apr 23, 2025 | EXHIBIT | PETITIONER |
Summons in District Court | Apr 23, 2025 | EXHIBIT | PETITIONER |
Motion for Entry of Scheduling Order | Apr 23, 2025 | EXHIBIT | PETITIONER |
Email regarding Updated Case Management Order | Apr 23, 2025 | EXHIBIT | PETITIONER |
Mylan Stipulation of Dismissal | Apr 23, 2025 | EXHIBIT | PETITIONER |
Proposed Case Management Order | Apr 23, 2025 | EXHIBIT | PETITIONER |
Reply to POPR | Apr 23, 2025 | PAPER | PETITIONER |
Ex. 3001 | Apr 10, 2025 | EXHIBIT | BOARD |
ORDER Conduct of the Proceeding Granting Request for Additional Briefing | Apr 10, 2025 | PAPER | BOARD |
Regeneron's Preliminary Patent Owner Response (IPR2025-00176) | Mar 17, 2025 | PAPER | PATENT OWNER |
Mylan Redacted Trial Decision, 22-cv-61, Dkt. 692 (N.D.W. Va.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
SB Redacted PI Decision, 24-md-3103, Dkt. 194 (N.D.W. Va.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Formycon Redacted PI Decision, 24-md-3103, Dkt. 247 (N.D.W. Va.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Celltrion Redacted PI Decision, 24-md-3103, Dkt. 248 (N.D.W. Va.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
SB Appeal Decision, 24-1965, Dkt. 76 (Fed. Cir.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Formycon Appeal Decision, 24-2009, Dkt. 67 (Fed. Cir.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Celltrion Appeal Decision, 24-2058, Dkt. 62 (Fed. Cir.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Exhibit A, Samsung Bioepis’s Proposed Schedule, 24-md-3103, Dkt. 478-1 (N.D.W. Va.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Regeneron Pharmaceuticals, Inc.’s Response, 24-md-3103, Dkt. 483 (N.D.W. Va.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Regeneron v. Mylan, 22-cv-61, Trial Transcript (Public Excerpts) (N.D.W. Va.) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
J.L. Fast et al., Physical Instability of a Therapeutic Fc Fusion Protein: Domain Contributions to Conformational and Colloidal Stability (2009) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Regeneron v. Mylan, 22-cv-61, Trial Ex. DTX-3619A, Fusion Proteins Disclosed in Papadopoulos | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
D. Ghate & H.F. Edelhauser, Ocular Drug Delivery (2006) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
T.L. Jackson et al., Human Retinal Molecular Weight Exclusion Limit and Estimate of Species Variation (2003) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
N. Ferrara et al., Development of Ranibizumab, an Anti–Vascular Endothelial Growth Factor Antigen Binding Fragment, as Therapy for Neovascular Age-Related Macular Degeneration (2006) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
A.M. Sinclair & S. Elliott, Glycoengineering: The Effect of Glycosylation on the Properties of Therapeutic Proteins (2005) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
J.A. Marinaro et al., O-glycosylation Delays the Clearance of Human IGF-Binding Protein-6 from the Circulation (2000) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
R.L. Shields et al., High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR* (2001) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
WO 2006/047325 | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
W. Wang, Protein Aggregation and Its Inhibition in Biopharmaceutics (2005) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
W. Wang, Instability, Stabilization, and Formulation of Liquid Protein Pharmaceuticals (1999) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
P.J. Rosenfeld et al., Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration (2005) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Stedmans Medical Dictionary 265360 | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Declaration of Kenneth S. Graham, dated April 18, 2024 | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
U.S. Patent Application Publication No. 2001/0014326 | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
U.S. Patent Application Publication No. 2003/0113316 | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
FDA Guidance for Industry, Stability Testing | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Thomas et al., Comparative Effectiveness of Aflibercept for the Treatment of Patients with Neovascular Age-Related Macular Degeneration (2013) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
N. Ferrara et al., Discovery and Development of Bevacizumab, an Anti-VEGF Antibody for Treating Cancer (2004) | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
OPUVIZ™ Label | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Eylea® Label | Mar 17, 2025 | EXHIBIT | PATENT OWNER |
Notice: Updated Mandatory Notice | Dec 31, 2024 | PAPER | PATENT OWNER |
Notice: Updated Power of Attorney | Dec 31, 2024 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Dec 17, 2024 | PAPER | BOARD |
Notice : Power of Attorney | Dec 11, 2024 | PAPER | PATENT OWNER |
Notice : Mandatory Notice | Dec 11, 2024 | PAPER | PATENT OWNER |
U.S. Patent No. 11,084,865 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Yaman Curriculum Vitae | Nov 20, 2024 | EXHIBIT | PETITIONER |
File History of U.S. Application No. 16/739,559 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Chaum Curriculum Vitae | Nov 20, 2024 | EXHIBIT | PETITIONER |
Holash | Nov 20, 2024 | EXHIBIT | PETITIONER |
February 3, 2006 Presentation | Nov 20, 2024 | EXHIBIT | PETITIONER |
February 8, 2006 Presentation | Nov 20, 2024 | EXHIBIT | PETITIONER |
March 8, 2006 Lehman Brothers Presentation | Nov 20, 2024 | EXHIBIT | PETITIONER |
Press Release “VEGF trap oncology program with Sanofi-Aventis planned..." | Nov 20, 2024 | EXHIBIT | PETITIONER |
Rudge 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Press Release, “Regeneron’s VEGF trap demonstrates positive preliminary..." | Nov 20, 2024 | EXHIBIT | PETITIONER |
Chang 2002 | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,374,758 | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,110,546 | Nov 20, 2024 | EXHIBIT | PETITIONER |
September 27, 2005 UBS Global Life Sciences Conference Presentation | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2003/0113316 to Kaisheva et al. | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2003/0138417 | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2004/0197324 | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2004/0265309 | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2005/0112061 | Nov 20, 2024 | EXHIBIT | PETITIONER |
International Publication No. WO 00/75319 | Nov 20, 2024 | EXHIBIT | PETITIONER |
International Publication No. WO 97/04801 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Merriam Webster Vial Definition | Nov 20, 2024 | EXHIBIT | PETITIONER |
AVASTIN Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
RAPTIVA Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
REMICADE Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
SIMULECT Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
HERCEPTIN Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
XOLAIR Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
FDA Container Closure Guidance | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Pub. No. 2006/0058234 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Butler Curriculum Vitae | Nov 20, 2024 | EXHIBIT | PETITIONER |
Chirila (1998) | Nov 20, 2024 | EXHIBIT | PETITIONER |
Neto 2023 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Eldeeb 2017 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Macugen Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
Vitravene Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
Vernon 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Jaffe 2006 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Rosenfeld 2006 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Rosenfeld 2003 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Costa 2006 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Rosenfeld 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Bonni-Filho 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Gillies 2003 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Eyetech Study | Nov 20, 2024 | EXHIBIT | PETITIONER |
Hida 1986 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Jonas 2003 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Danis 2000 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Young 2001 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Kenalog Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
Jonas 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Gallemore | Nov 20, 2024 | EXHIBIT | PETITIONER |
Kupperman I | Nov 20, 2024 | EXHIBIT | PETITIONER |
Kuppermann II | Nov 20, 2024 | EXHIBIT | PETITIONER |
Vitrase Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
Gaudreault 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Lucentis Label | Nov 20, 2024 | EXHIBIT | PETITIONER |
CATT Study | Nov 20, 2024 | EXHIBIT | PETITIONER |
Oliveira 2001 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Wang 2004 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Tezel 1998 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Tsui 2012 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Sakuma 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Gandorfer 2004 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Malik 2014 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Application for Extension of Patent Term to U.S. Patent No. 7,374,758 | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Pub. No. 2004/0014667 | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Pub. No. 2005/0175610 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Drickamer 1998 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Kimura 1997 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Baker 2001 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Kobata 2000 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Dwek 1995 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Liu 2015 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Jefferis 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
’992 IPR POR | Nov 20, 2024 | EXHIBIT | PETITIONER |
Ronin 1981 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Imperiali 1995 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Anguita 2021 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Hart 1992 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Jager 2004 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Garcia-Valldecabres 2004 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Andya 2003 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Parkins 2000 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Nov 22 OA Response | Nov 20, 2024 | EXHIBIT | PETITIONER |
U.S. Patent Pub. No. 2005/0281822 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Garcia-Carmona 2003 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Manning Declaration - IPR2021-00881 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Sigma Polysorbate 20 Product Information | Nov 20, 2024 | EXHIBIT | PETITIONER |
Cheng 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Illingworth 1981 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Chan 1998 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Hanna 2004 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Oakton 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Regeneron Appeal Responsive Brief | Nov 20, 2024 | EXHIBIT | PETITIONER |
Samsung Bioepis’s Motion for Status Conference | Nov 20, 2024 | EXHIBIT | PETITIONER |
Regeneron’s Response to Motion for Status Conference | Nov 20, 2024 | EXHIBIT | PETITIONER |
Mylan Emergency Motion from Mylan Litigation | Nov 20, 2024 | EXHIBIT | PETITIONER |
Regeneron’s Response to April Emergency Motion from Mylan Litigation | Nov 20, 2024 | EXHIBIT | PETITIONER |
Status Conference Transcript from Mylan Litigation | Nov 20, 2024 | EXHIBIT | PETITIONER |
Macugen Approval Letter | Nov 20, 2024 | EXHIBIT | PETITIONER |
Notice : Power of Attorney | Nov 20, 2024 | PAPER | PETITIONER |
Ansel 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Ferrara 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Fraser 2005 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Wulff 2002 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Corderio 2006 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Nayar 2002 | Nov 20, 2024 | EXHIBIT | PETITIONER |
Petition : as filed | Nov 20, 2024 | PAPER | PETITIONER |
Yaman Declaration | Nov 20, 2024 | EXHIBIT | PETITIONER |
Chaum Declaration | Nov 20, 2024 | EXHIBIT | PETITIONER |
Butler Declaration | Nov 20, 2024 | EXHIBIT | PETITIONER |